KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

NovoCure (NVCR) Receivables - Net (2016 - 2025)

NovoCure (NVCR) has disclosed Receivables - Net for 12 consecutive years, with $58.7 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 67.32% to $58.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $58.7 million through Dec 2025, up 67.32% year-over-year, with the annual reading at $58.7 million for FY2025, 67.32% up from the prior year.
  • Receivables - Net hit $58.7 million in Q4 2025 for NovoCure, down from $85.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $101.0 million in Q1 2022 to a low of $17.0 million in Q4 2021.
  • Historically, Receivables - Net has averaged $44.7 million across 5 years, with a median of $33.5 million in 2024.
  • Biggest five-year swings in Receivables - Net: tumbled 79.88% in 2022 and later soared 290.15% in 2023.
  • Year by year, Receivables - Net stood at $17.0 million in 2021, then soared by 52.48% to $26.0 million in 2022, then fell by 12.64% to $22.7 million in 2023, then surged by 54.62% to $35.1 million in 2024, then soared by 67.32% to $58.7 million in 2025.
  • Business Quant data shows Receivables - Net for NVCR at $58.7 million in Q4 2025, $85.2 million in Q3 2025, and $39.1 million in Q2 2025.